Replies to post #44581 on Relief Therapeutics Holding AG (RLFTF)

[Joe Kaplan]

Excellent, excellent News, thanks Panton for the info on the RLF cancer med TD 011.
With a north american market value projected at over half a billion by 2028, it might be interesting
to speculate on the GLOBAL market value at that time or for this year. .
And thats not to mention other potential cancer applications for Relief Therapeutics.

Please refresh my thoughts on market value projections for CIP, ARDS or Sarcoidosis.